Croma-Pharma is the first company worldwide to achieve MDR approval in the aesthetic field

• “saypha^® RICH“ is the first dermal filler to meet the strict requirements of the EU Medical Device Regulation for aesthetic treatments (MDR Annex XVI)
• Approval as a guarantee for product quality, patient safety and efficiency
• Milestone in Croma's corporate history and global growth strategy